A detailed history of Natixis Advisors, L.P. transactions in Medtronic PLC stock. As of the latest transaction made, Natixis Advisors, L.P. holds 1,344,210 shares of MDT stock, worth $109 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
1,344,210
Previous 1,185,911 13.35%
Holding current value
$109 Million
Previous $93.3 Million 29.65%
% of portfolio
0.24%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$76.84 - $91.03 $12.2 Million - $14.4 Million
158,299 Added 13.35%
1,344,210 $121 Million
Q2 2024

Aug 01, 2024

BUY
$78.71 - $87.02 $8.45 Million - $9.34 Million
107,329 Added 9.95%
1,185,911 $93.3 Million
Q1 2024

Apr 25, 2024

BUY
$82.84 - $88.09 $1.26 Million - $1.34 Million
15,245 Added 1.43%
1,078,582 $94 Million
Q4 2023

Feb 06, 2024

BUY
$69.43 - $83.43 $5.82 Million - $6.99 Million
83,816 Added 8.56%
1,063,337 $87.6 Million
Q3 2023

Nov 13, 2023

BUY
$78.22 - $90.4 $4.34 Million - $5.01 Million
55,433 Added 6.0%
979,521 $76.8 Million
Q2 2023

Aug 15, 2023

BUY
$79.47 - $91.38 $7.33 Million - $8.42 Million
92,178 Added 11.08%
924,088 $81.4 Million
Q1 2023

May 11, 2023

BUY
$76.72 - $87.58 $26.6 Million - $30.4 Million
347,282 Added 71.66%
831,910 $67.1 Million
Q4 2022

Jan 27, 2023

SELL
$76.18 - $87.74 $19.7 Million - $22.7 Million
-258,947 Reduced 34.82%
484,628 $37.7 Million
Q3 2022

Nov 14, 2022

BUY
$80.75 - $95.31 $20.6 Million - $24.4 Million
255,695 Added 52.41%
743,575 $60 Million
Q2 2022

Aug 12, 2022

SELL
$87.4 - $113.09 $16.9 Million - $21.8 Million
-192,957 Reduced 28.34%
487,880 $43.8 Million
Q1 2022

May 12, 2022

SELL
$100.58 - $112.38 $6.28 Million - $7.02 Million
-62,443 Reduced 8.4%
680,837 $75.5 Million
Q4 2021

Feb 08, 2022

SELL
$99.53 - $127.75 $12.4 Million - $15.9 Million
-124,493 Reduced 14.35%
743,280 $76.9 Million
Q3 2021

Nov 15, 2021

BUY
$122.75 - $135.17 $11.8 Million - $13 Million
96,083 Added 12.45%
867,773 $109 Million
Q2 2021

Aug 12, 2021

SELL
$118.19 - $131.5 $8.27 Million - $9.2 Million
-69,987 Reduced 8.32%
771,690 $95.8 Million
Q1 2021

May 05, 2021

BUY
$111.18 - $119.74 $3.4 Million - $3.66 Million
30,587 Added 3.77%
841,677 $99.4 Million
Q4 2020

Feb 12, 2021

SELL
$100.57 - $117.14 $2.24 Million - $2.61 Million
-22,267 Reduced 2.67%
811,090 $95 Million
Q3 2020

Nov 12, 2020

BUY
$90.13 - $108.78 $4.09 Million - $4.93 Million
45,327 Added 5.75%
833,357 $86.6 Million
Q2 2020

Aug 11, 2020

BUY
$84.11 - $103.33 $1.51 Million - $1.85 Million
17,931 Added 2.33%
788,030 $72.3 Million
Q1 2020

Apr 27, 2020

SELL
$72.92 - $121.3 $6.49 Million - $10.8 Million
-88,938 Reduced 10.35%
770,099 $69.4 Million
Q4 2019

Feb 10, 2020

BUY
$104.49 - $114.54 $6.3 Million - $6.9 Million
60,247 Added 7.54%
859,037 $97.5 Million
Q3 2019

Nov 12, 2019

BUY
$98.02 - $111.18 $6.74 Million - $7.64 Million
68,739 Added 9.42%
798,790 $86.8 Million
Q2 2019

Aug 12, 2019

BUY
$84.15 - $99.38 $3.85 Million - $4.55 Million
45,798 Added 6.69%
730,051 $71.1 Million
Q1 2019

May 15, 2019

BUY
$82.45 - $93.79 $4.48 Million - $5.1 Million
54,394 Added 8.64%
684,253 $62.3 Million
Q4 2018

Feb 13, 2019

BUY
$85.8 - $99.49 $420,849 - $487,998
4,905 Added 0.78%
629,859 $57.3 Million
Q3 2018

Nov 13, 2018

BUY
$85.91 - $99.17 $473,879 - $547,021
5,516 Added 0.89%
624,954 $61.5 Million
Q2 2018

Aug 14, 2018

SELL
$77.48 - $87.83 $9.59 Million - $10.9 Million
-123,771 Reduced 16.65%
619,438 $0
Q1 2018

May 10, 2018

BUY
$76.55 - $87.26 $2.64 Million - $3.01 Million
34,443 Added 4.86%
743,209 $59.6 Million
Q4 2017

Feb 14, 2018

BUY
$76.93 - $83.5 $12 Million - $13 Million
156,175 Added 28.26%
708,766 $57.2 Million
Q3 2017

Nov 14, 2017

BUY
$77.71 - $84.6 $42.9 Million - $46.7 Million
552,591
552,591 $43 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.